Reply to Ogimoto, angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy (Am Heart J 2005;149:e19.)

Am Heart J. 2005 Jul;150(1):e5. doi: 10.1016/j.ahj.2004.09.024.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Atrial Fibrillation / drug therapy*
  • Humans

Substances

  • Angiotensin-Converting Enzyme Inhibitors